LINK 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-08-13

• Other income/expense consists of non-operating income and expenses, such as gains and losses on marketable securities, foreign currency transaction gains and losses, interest income and expense, and other non-operating income and expenses. Other income/expense for the three months ended June 30, 202…

• Revenues were up in the six months ended June 30, 2026 compared to the six months ended June 30, 2025 for customers in the medical and automotive markets and for customers of our standard products and were down for customers in the industrial market. The increase in revenue from customers in the med…

• Gross profit was up during the six months ended June 30, 2026 compared to the six months ended June 30, 2025 due primarily to higher revenues, and gross margin percentage increased due to favorable changes in our product and customer mix.

• Engineering and R&D costs for the six months ended June 30, 2026 were down compared to the six months ended June 30, 2025 due to lower engineering employee and consultant compensation costs.

• Selling, general and administrative costs for the six months ended June 30, 2026 were up compared to the six months ended June 30, 2025 due to higher costs for compensation, professional fees and consultants.

相对上期删除的文字 · 来源:10-Q · 2026-05-14

• instruments at the facility in Fremont, California. Our vertically integrated manufacturing approach allows us to maintain control over proprietary processes, quality standards, and supply chain responsiveness.

• Other income (expense) consists of non-operating income and expenses, such as gains and losses on marketable securities, foreign currency transaction gains and losses, interest income and expense, and other non-operating income and expenses. Other income (expense) for the three months ended March 31…

• Cash requirements for working capital, capital expenditures, and acquisition activities have historically been funded from our cash balances, cash generated from operations, and issuances of equity securities. As of March 31, 2026, we had cash and cash equivalents of $2.1 million, working capital of…

• No cash was provided by or used in investing activities for the three months ended March 31, 2026. Net cash used in investing activities of $29,000 for the three months ended March 31, 2025 consisted of purchases of property, plant, and equipment.